Clinical trial
The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD
NCT00274222 is registered in ClinicalTrials.gov with Inonu University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD
- Lead sponsor
- Inonu University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2003
- Completion date
- October 31, 2005
- Enrollment
- 120
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
copd acute exacerbation